Head, Division of Surgery, Professor and Chair Department of Thoracic and Cardiovascular Surgery, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, University of Texas MD Anderson Cancer Center
Thoracic Surgery
Dr. Stephen G. Swisher, MD
|
|
Give Review
Stephen Swisher is an expert in the field of Thoracic Surgery. He went to medical school at University of California San Diego School of Medicine. University of California San Diego School of Medicine has a rank of 17 in research and a 19 in primary care He received 5 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Fellow (FACS)" and "Super Doctor". Stephen Swisher is a published doctor as well. He has 98 publications published. The latest was: Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Radiation modality use and cardiopulmonary mortality risk in elderly patients with Esophageal cancer.
- Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
- Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer.
- Endoscopic Ultrasound Estimates for Tumor Depth at the GastroEsophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection.
- Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry.
- RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung Cancer.
- Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
- A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for Esophageal cancer.
- Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung Cancer.
- Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management.
- Expression of sulfotransferase SULT1A1 in Cancer cells predicts susceptibility to the novel antiCancer agent NSC-743380.
- Lobectomy, Sublobar Resection, and Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancers in the Elderly.
- Intratumor heterogeneity in localized Lung adenocarcinomas delineated by multiregion sequencing.
- Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380.
- Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
- Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy.
- Impact of a Fast-Track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges.
- Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer.
- Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?
- Preoperative chemotherapy prior to Pulmonary metastasectomy in surgically resected primary colorectal carcinoma.
- Signet Ring Cells in Esophageal Adenocarcinoma Predict Poor Response to Preoperative Chemoradiation.
- Optimizing Surrogate End Points for Preoperative Systemic Therapies in Non-Small Cell Lung Cancers.
- Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung Cancer.
- Influence of preoperative radiation field on postoperative leak rates in Esophageal cancer patients after trimodality therapy.
- Three Angels are Dancing on the Head of the Esophageal Cancer Pin, but Shouldn't We Not Topple One or Two?
- Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung Cancer: how to fly in a "no fly zo...
- Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lun...
- Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung Cancer.
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung Cancers: proposal for the use of major pathological response as a surrogate endp...
- EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma.
- Prediction of survival in resected non-small cell lung Cancer using a protein-expression based risk model: Implications for personalized chemoprevention and therapy.
- Salvage esophagectomy in the management of recurrent or persistent Esophageal carcinoma.
- IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non-Small Cell Lung Cancer Cells.
- Factors Associated with Local-Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer.
- Serious postoperative infections following resection of common solid Tumors: outcomes, costs, and impact of hospital surgical volume.
- Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies.
- Concordance of studies for nodal staging is prognostic for worse survival in Esophageal cancer.
- Validation of a Proliferation-based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma.
- Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or GastroEsophageal Cancer: Implications for Screening and Surveillance.
- The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma.
- Predictors of postoperative complications after trimodality therapy for Esophageal cancer.
- Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation.
- Pretreatment Patient Comorbidity and Tobacco Use Increase Cost and Risk of Postoperative Complications After Esophagectomy at a High-Volume Cancer Center.
- Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung Cancer.
- Visceral pleural invasion is not predictive of survival in patients with lung Cancer and smaller tumor size.
- Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroEsophageal cancer: analysis ...
- Surgery Is an Essential Component of Multimodality Therapy for Patients with Locally Advanced Esophageal Adenocarcinoma.
- Obesity and outcomes in patients treated with chemoradiotherapy for Esophageal carcinoma.
- FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies.
- Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC.
- Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience.
- Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant C...
- Utilization of surgery in trimodality-eligible patients with locally advanced Esophageal adenocarcinoma in a nonprotocol setting.
- Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung Cancer, with implications for patient selection for adjuvant radiati...
- Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery.
- Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer.
- Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with Esophageal cancer.
- Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly.
- Patients with high body mass index tend to have lower stage of Esophageal carcinoma at diagnosis.
- Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma.
- Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary Cancer center is safe and reveals nonCancerous, noninfectious entities as the most co...
- Tissue Platinum Concentration and Tumor Response in Non-Small-Cell Lung Cancer.
- Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer.
- A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oEsophageal cancer.
- Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy.
- Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis.
- Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy.
- Proton Beam Therapy and Concurrent Chemotherapy for Esophageal Cancer.
- Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial Esophageal cancers: a systematic review and meta-analysis.
- Authors' respone.
- Role of imaging in the diagnosis, staging, and treatment of thymoma.
- Preoperative Chemotherapy for Localized Squamous Cell Carcinoma of the Esophagus? We Should Go Back to the Drawing Board!
- Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?
- Improved survival after resection of liver and Lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited Lung metastatic dis...
- A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus Tumors.
- Computed Tomography Findings Predicting Invasiveness of Thymoma.
- Celebrate or Calibrate? We Say Calibrate.
- Duplicated Muscularis Mucosae Invasion has Similar Risk of Lymph Node Metastasis and Recurrence-free Survival as Intramucosal Esophageal Adenocarcinoma.
- Progression after chemotherapy is a novel predictor of poor outcomes after Pulmonary metastasectomy in sarcoma patients.
- A Phase II Study of a Paclitaxel-based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporti...
- The prognostic factors of chest wall metastasis resection.
- Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with Esophageal or gastroEsophageal junction ...
- Combined modality therapy of cT2N0M0 Esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.
- Toxicity and Patterns of Failure of Adaptive/Ablative Proton Therapy for Early-Stage, Medically Inoperable Non-Small Cell Lung Cancer.
- The Role of PKR/eIF2? Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer.
- Prognostic significance of differentially expressed miRNAs in Esophageal cancer.
- The influence of high body mass index on the prognosis of patients with Esophageal cancer after surgery as primary therapy.
- Prognostic significance of RNA-dependent protein kinase on non-small cell lung Cancer patients.
- Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience.
- Critical role of surgery in patients with gastroEsophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
- Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and Esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
- Genetically abnormal circulating cells in lung Cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
- Nrf2 and Keap1 abnormalities in non-small cell Lung carcinoma and association with clinicopathologic features.
- Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroEsophageal junction.
- KLF4 inhibition of lung Cancer cell invasion by suppression of SPARC expression.
- Absence of pRb facilitates E2F1-induced apoptosis in breast Cancer cells.
- Prognostic biomarkers for Esophageal adenocarcinoma identified by analysis of tumor transcriptome.
Schools
Univ Of Ca
Mem Hermann Hlthcare Sys
UCLA Med Center
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiac Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
- Super Doctor
Education
-
UCLA Medical Center -
University of California San Diego School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1063518959 | |
| NPPES Provider LastName | SWISHER | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Thoracic Surgery | |
| Total Claim Count | 70.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 24.29 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063518959 |
| Last Name Of The Provider | SWISHER |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Joseph S. Coselli, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lorraine D. Cornwell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Min P. Kim, MD |
|
|
Dr. Boris Sepesi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Fetter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey S. Heinle, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tom C. Nguyen, MD |
|
|
Dr. Fareed A. Khouqeer, MD |
|
Dr. Hazim J. Safi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adel D. Irani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John E. Rea III, MD
This Doctor is OpenDoctor Recommended.
|